Shilpa Medicare Ltd.

NSE: SHILPAMED | BSE: 530549 | ISIN: INE790G01031 | Industry: Pharmaceuticals
| Mid-range Performer
898.8000 -7.10 (-0.78%)
NSE Jul 15, 2025 15:29 PM
Volume: 53,870
 

898.80
-0.78%
AUM Capital
Shilpa Medicare Ltd. (SML), established in 1987 at Raichur, Karnataka is engaged in the production and exports of consistently high-quality Active Pharmaceutical Ingredients (API) Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications with Mr. Omprakash Inani as Chairman and Mr. Vishnukant C. Bhutada as MD. Over the period of time, it has shifted its focus towards creating a niche in pharmaceutical manufacturing particularly in Oncology generics. It is one of the leaders in the Oncology market and offers a complete range of products in this segment spanning across APIs, formulations both in terms of R&D; and manufacturing capabilities along...
Shilpa Medicare Ltd. is trading below its 30 day SMA of 900.2
More from Shilpa Medicare Ltd.
Recommended